Victory Capital Management Inc Inmune Bio, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$3.1 - $6.09 $2,263 - $4,445	-730 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$2.21 - $6.15 $35 - $98	-16 Reduced 2.14%	730 $2,000
Q4 2019 Feb 04, 2020	SELL	$3.56 - $6.1 $345 - $591	-97 Reduced 11.51%	746 $4,000
Q3 2019 Nov 12, 2019	BUY	$5.32 - $10.0 $4,484 - $8,430	843 New	843 $5,000

5.88M

243K

46.4K

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $89M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.